As of 2025-12-16, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 15.4x | 15.2x |
| Forward P/E multiples | 21.8x - 53.1x | 37.4x |
| Fair Price | (4.27) - (2.48) | (5.54) |
| Upside | -113.7% - -107.9% | -117.7% |
| Date | EV/EBITDA |